Transdermal Contraception Patch: EU Cycle Control Study Versus EVRA.

Trial Profile

Transdermal Contraception Patch: EU Cycle Control Study Versus EVRA.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Ethinylestradiol/gestodene (Primary) ; Ethinylestradiol/norelgestromin
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 19 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jun 2010 Actual patient number (391) added as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top